Zentalis Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.09 | -100% | -9.24 | -100% |
| P/S |
|
0 | 33.5 | -100% |
|
|
| P/BV |
|
2.29 | 4.61 | -50.35% |
|
|
| P/FCF |
|
-8.73 | 39.66 | -122.02% |
|
|
| Ev/Ebitda |
|
-4.04 | -19.46 | -79.25% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-4.89 | 45.47 | -110.76% |
|
|
| E/P |
|
-0.1605 | 0.0172 | -1030.58% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -14.42 | -100% | -30017.14 | -100% |
| ROE |
|
-66.82 | 9.01 | -841.58% |
|
|
| ROA |
|
-51.99 | 0.0151 | -343379.54% |
|
|
| ROIC |
|
-49.67 | 7.63 | -750.61% |
|
|
| ROS |
|
0 | -26.5 | -100% |
|
|
| ROCE |
|
-58.06 | 13.75 | -522.16% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1812 | -3.73 | -95.14% | -0.1791 | +1.2% |
| Nеt Debt/Ebitda |
|
-0.0702 | -3.19 | -97.8% |
|
|
| Debt/Ratio |
|
0.0814 | 0.1777 | -54.17% |
|
|
| Debt/Equity |
|
5.94 | 1.57 | 278.26% |
|
|
| Debt/Net Income |
|
-0.1567 | 0.8429 | -118.58% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5467 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4967 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.73 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5467 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | 73.67 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
489.94 | 15.28 | 3106.41% | ||
| Growth impulse Net Income in 5 years |
|
535.2 | -33.08 | -1717.9% | ||
| Growth impulse FCF in 5 years |
|
434.37 | -6.99 | -6314.16% | ||
| Growth impulse EPS in 5 years |
|
221.38 | -59.11 | -474.52% |
IP Score
3.83/10
